Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Soleno Therapeutics Inc | 274,424 | 494,424 | +220,000 | $13.86M | $22.22M | 8.96% | +$8.37M |
| Merus N V | 80,171 | 463,840 | +383,669 | $4.01M | $19.50M | 7.87% | +$15.50M |
| Intra-Cellular Therapies Inc | 216,519 | 219,719 | +3,200 | $15.84M | $18.35M | 7.40% | +$2.51M |
| Arcellx Inc COMMON STOCK | 0 | 229,785 | +229,785 | $0 | $17.62M | 7.11% | +$17.62M |
| Novo Nordisk A/SADR(NVO) | 741,743 | 200,000 | -541,743 | $88.32M | $17.20M | 6.94% | -$71.12M |
| Nuvalent Inc | 15,437 | 204,045 | +188,608 | $1.58M | $15.97M | 6.44% | +$14.39M |
| Vaxcyte, Inc.(PCVX) | 76,255 | 162,255 | +86,000 | $8.71M | $13.28M | 5.36% | +$4.57M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 35,000 | 56,400 | +21,400 | $9.63M | $13.27M | 5.35% | +$3.65M |
| AstraZeneca PLCADR(AZN) | 190,752 | 190,752 | 0 | $14.86M | $12.50M | 5.04% | -$2.36M |
| Revolution Medicines, Inc.(RVMD) | 95,885 | 284,190 | +188,305 | $4.35M | $12.43M | 5.01% | +$8.08M |
| Verona Pharma PlcADS | 148,590 | 255,318 | +106,728 | $4.27M | $11.86M | 4.78% | +$7.58M |
| Insmed Incorporated(INSM) | 52,939 | 167,939 | +115,000 | $3.86M | $11.59M | 4.68% | +$7.73M |
| Protagonist Therapeutics Inc | 124,440 | 293,851 | +169,411 | $5.60M | $11.34M | 4.57% | +$5.74M |
| Janux Therapeutics, Inc.(JANX) | 0 | 162,976 | +162,976 | $0 | $8.73M | 3.52% | +$8.73M |
| argenx SEADR(ARGX) | 15,138 | 11,311 | -3,827 | $8.21M | $6.96M | 2.81% | -$1.25M |
| Neurocrine Biosciences, Inc.(NBIX) | 45,000 | 45,000 | 0 | $5.18M | $6.14M | 2.48% | +$957.6K |
| Viking Therapeutics, Inc.(VKTX) | 532,879 | 90,279 | -442,600 | $33.74M | $3.63M | 1.47% | -$30.10M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 50,000 | +50,000 | $0 | $2.80M | 1.13% | +$2.80M |
| Crinetics Pharmaceuticals In | 45,765 | 45,765 | 0 | $2.34M | $2.34M | 0.94% | +$1.4K |
| Enliven Therapeutics Inc | 0 | 102,900 | +102,900 | $0 | $2.32M | 0.93% | +$2.32M |
| Springworks Therapeutics Inc | 53,930 | 53,930 | 0 | $1.73M | $1.95M | 0.79% | +$220.6K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 100,000 | +100,000 | $0 | $1.92M | 0.77% | +$1.92M |
| TG Therapeutics, Inc.(TGTX) | 0 | 54,515 | +54,515 | $0 | $1.64M | 0.66% | +$1.64M |
| EyePoint, Inc.(EYPT) | 156,300 | 216,700 | +60,400 | $1.25M | $1.61M | 0.65% | +$365.6K |
| Xenon Pharmaceuticals Inc.(XENE) | 40,000 | 40,000 | 0 | $1.57M | $1.57M | 0.63% | -$6.8K |
| Mereo BioPharma Group plcADS(MREO) | 421,359 | 421,359 | 0 | $1.73M | $1.47M | 0.59% | -$257.0K |
| Newamsterdam Pharma Company ORDINARY SHARES | 54,285 | 54,285 | 0 | $901.1K | $1.40M | 0.56% | +$494.0K |
| Centessa Pharmaceuticals PlcADS | 80,380 | 80,380 | 0 | $1.29M | $1.35M | 0.54% | +$61.1K |
| Charles River Laboratories International, Inc.(CRL) | 6,305 | 6,305 | 0 | $1.24M | $1.16M | 0.47% | -$78.0K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 20,811 | +20,811 | $0 | $1.15M | 0.46% | +$1.15M |
| Ascendis Pharma A/SADR(ASND) | 7,440 | 7,440 | 0 | $1.11M | $1.02M | 0.41% | -$86.6K |
| Annexon, Inc.(ANNX) | 172,226 | 172,226 | 0 | $1.02M | $883.5K | 0.36% | -$136.1K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 16,650 | +16,650 | $0 | $768.7K | 0.31% | +$768.7K |
| Acelyrin Inc | 93,114 | 0 | -93,114 | $459.1K | $0 | — | -$459.1K |
| Alector Inc | 193,317 | 0 | -193,317 | $900.9K | $0 | — | -$900.9K |
| Axsome Therapeutics, Inc.(AXSM) | 87,848 | 0 | -87,848 | $7.89M | $0 | — | -$7.89M |
| Celldex Therapeutics, Inc.(CLDX) | 75,300 | 0 | -75,300 | $2.56M | $0 | — | -$2.56M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 47,400 | 0 | -47,400 | $977.9K | $0 | — | -$977.9K |
| Disc Medicine, Inc.(IRON) | 13,440 | 0 | -13,440 | $660.4K | $0 | — | -$660.4K |
| Dyne Therapeutics, Inc.(DYN) | 119,488 | 0 | -119,488 | $4.29M | $0 | — | -$4.29M |
| Eli Lilly and Company(LLY) | 92,593 | 0 | -92,593 | $82.03M | $0 | — | -$82.03M |
| IDEAYA Biosciences, Inc.(IDYA) | 62,992 | 0 | -62,992 | $2.00M | $0 | — | -$2.00M |
| Ionis Pharmaceuticals, Inc.(IONS) | 30,479 | 0 | -30,479 | $1.22M | $0 | — | -$1.22M |
| Keros Therapeutics, Inc.(KROS) | 20,000 | 0 | -20,000 | $1.16M | $0 | — | -$1.16M |
| Kura Oncology, Inc.(KURA) | 57,178 | 0 | -57,178 | $1.12M | $0 | — | -$1.12M |
| Larimar Therapeutics, Inc.(LRMR) | 90,490 | 0 | -90,490 | $592.7K | $0 | — | -$592.7K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,557 | 0 | -1,557 | $330.4K | $0 | — | -$330.4K |
| Q32 Bio Inc.(QTTB) | 4,705 | 0 | -4,705 | $209.9K | $0 | — | -$209.9K |
| Silence Therapeutics plcADS(SLN) | 52,476 | 0 | -52,476 | $954.0K | $0 | — | -$954.0K |
| Summit Therapeutics Inc.(SMMT) | 14,512 | 0 | -14,512 | $317.8K | $0 | — | -$317.8K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 48,263 | 0 | -48,263 | $929.1K | $0 | — | -$929.1K |
| Vertex Pharmaceuticals Incorporated(VRTX) | 18,900 | 0 | -18,900 | $8.79M | $0 | — | -$8.79M |